LD-2 disclosure · 1st Quarter - Report
SHIRE PHARMACEUTICALS LLC
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Pharmaceutical Company
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesTaxation/Internal Revenue Code
Orphan drug tax credit
LobbyistsJED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing
LobbyistsMARK LENKER · ENGEL BURNS · JED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration
LobbyistsENGEL BURNS · JED PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
ADHD Awareness *Drug Values -Binge Eating Disorder awareness -DEA processes and re-exportation -FDA Funding -Medicaid rare disease patient access to therapy -Orphan drug tax credit -Orphan Drug Act regulations -HR 1628 - American Health Care Act of 2017 -PDUFA Reauthorization